| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,027 |
10,358 |
$1.68M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,959 |
7,182 |
$1.26M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,062 |
6,627 |
$1.06M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
15,290 |
4,242 |
$1.05M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,084 |
2,684 |
$1.01M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,293 |
1,245 |
$1.00M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,762 |
2,535 |
$440K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,845 |
1,753 |
$260K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
7,473 |
6,832 |
$221K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,513 |
1,442 |
$210K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,963 |
3,493 |
$205K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,465 |
1,415 |
$185K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,615 |
1,512 |
$172K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,912 |
1,889 |
$156K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,267 |
847 |
$155K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
158 |
158 |
$136K |
| 97162 |
|
1,732 |
1,675 |
$130K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,981 |
1,350 |
$86K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,071 |
1,802 |
$69K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,898 |
3,511 |
$68K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,274 |
12,838 |
$66K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,155 |
1,103 |
$60K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,299 |
975 |
$60K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,497 |
2,350 |
$59K |
| 71046 |
Radiologic examination, chest; 2 views |
4,326 |
4,085 |
$54K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
35 |
35 |
$51K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,018 |
1,994 |
$46K |
| ATP14 |
|
5,474 |
4,381 |
$41K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
196 |
190 |
$41K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
283 |
253 |
$39K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
478 |
450 |
$38K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
356 |
338 |
$37K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
346 |
338 |
$35K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,374 |
4,876 |
$32K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,155 |
1,145 |
$31K |
| 97113 |
|
645 |
193 |
$30K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,635 |
3,010 |
$29K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
225 |
215 |
$29K |
| 80053 |
Comprehensive metabolic panel |
11,881 |
10,444 |
$27K |
| 76830 |
Ultrasound, transvaginal |
279 |
274 |
$26K |
| 93017 |
|
251 |
237 |
$25K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
917 |
809 |
$20K |
| 84484 |
|
4,041 |
2,681 |
$19K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,667 |
5,035 |
$18K |
| ATP08 |
|
2,967 |
2,426 |
$18K |
| 64493 |
|
30 |
30 |
$17K |
| 93971 |
|
14 |
13 |
$16K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,277 |
2,186 |
$16K |
| 95886 |
|
76 |
69 |
$15K |
| 88142 |
|
905 |
897 |
$15K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,299 |
3,045 |
$15K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
250 |
244 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,531 |
770 |
$13K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
129 |
119 |
$13K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
793 |
772 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,783 |
5,938 |
$12K |
| 76536 |
|
95 |
93 |
$11K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
39 |
36 |
$10K |
| 20553 |
|
83 |
72 |
$10K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
69 |
65 |
$10K |
| 83690 |
|
2,084 |
1,886 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,148 |
2,063 |
$8K |
| 81001 |
|
4,717 |
4,340 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
310 |
304 |
$8K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
299 |
289 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
299 |
289 |
$7K |
| 97803 |
|
124 |
116 |
$7K |
| 20610 |
|
46 |
40 |
$7K |
| 83735 |
|
2,030 |
1,679 |
$7K |
| 84600 |
|
614 |
546 |
$7K |
| G0378 |
Hospital observation service, per hour |
515 |
267 |
$7K |
| 73562 |
|
269 |
243 |
$7K |
| 81025 |
|
1,240 |
1,166 |
$6K |
| 87632 |
|
43 |
34 |
$6K |
| 77080 |
|
116 |
113 |
$6K |
| 80050 |
General health panel |
319 |
303 |
$5K |
| 85027 |
|
1,684 |
1,472 |
$5K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$5K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
71 |
65 |
$4K |
| 73630 |
|
187 |
164 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,316 |
1,115 |
$4K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
682 |
581 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
12,127 |
9,267 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
4,156 |
3,507 |
$3K |
| ATP17 |
|
581 |
527 |
$3K |
| 76642 |
|
53 |
44 |
$3K |
| 71250 |
|
57 |
54 |
$3K |
| 84703 |
|
533 |
498 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,311 |
2,657 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
88 |
76 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,162 |
890 |
$3K |
| 85610 |
|
1,615 |
1,132 |
$3K |
| 83880 |
|
243 |
220 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,070 |
1,611 |
$3K |
| 87186 |
|
531 |
490 |
$3K |
| 73030 |
|
88 |
81 |
$2K |
| 84439 |
|
444 |
422 |
$2K |
| 87077 |
|
484 |
455 |
$2K |
| 64494 |
|
34 |
29 |
$2K |
| 73610 |
|
70 |
62 |
$2K |
| 81003 |
|
1,552 |
1,460 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,157 |
2,729 |
$2K |
| 85379 |
|
267 |
244 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
411 |
379 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
2,661 |
2,448 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
736 |
641 |
$1K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
16 |
12 |
$1K |
| 77065 |
Tomosynthesis, mammo |
29 |
27 |
$1K |
| 82728 |
|
167 |
157 |
$1K |
| ATP15 |
|
195 |
143 |
$1K |
| 82607 |
|
133 |
129 |
$1K |
| 73502 |
|
41 |
37 |
$877.69 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,210 |
2,558 |
$863.56 |
| ATP03 |
|
232 |
193 |
$836.46 |
| J3490 |
Unclassified drugs |
19 |
18 |
$833.16 |
| 83540 |
|
198 |
187 |
$727.52 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
107 |
79 |
$723.41 |
| 83605 |
|
123 |
102 |
$667.05 |
| 87486 |
|
26 |
26 |
$640.20 |
| 82947 |
|
1,191 |
787 |
$626.32 |
| 82570 |
|
198 |
196 |
$496.00 |
| 85652 |
|
345 |
312 |
$493.48 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
136 |
82 |
$454.64 |
| 90715 |
|
12 |
12 |
$413.58 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
850 |
841 |
$351.00 |
| J2060 |
Injection, lorazepam, 2 mg |
188 |
131 |
$336.96 |
| 84466 |
|
42 |
42 |
$323.01 |
| 73130 |
|
12 |
12 |
$315.32 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
37 |
37 |
$295.73 |
| 87807 |
|
25 |
25 |
$219.45 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
12 |
12 |
$211.23 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,522 |
2,224 |
$206.75 |
| 71045 |
Radiologic examination, chest; single view |
803 |
741 |
$201.88 |
| 86140 |
|
58 |
49 |
$189.28 |
| 80061 |
Lipid panel |
2,031 |
1,974 |
$178.98 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,307 |
1,232 |
$171.56 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
266 |
172 |
$168.91 |
| 87040 |
|
21 |
12 |
$138.45 |
| 85730 |
|
41 |
37 |
$122.00 |
| 87081 |
|
25 |
25 |
$115.12 |
| 83550 |
|
16 |
14 |
$72.16 |
| 87070 |
|
14 |
14 |
$71.04 |
| 88342 |
|
432 |
416 |
$56.76 |
| 87088 |
|
14 |
12 |
$51.66 |
| 85651 |
|
20 |
16 |
$43.80 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$40.10 |
| 85007 |
|
13 |
13 |
$21.91 |
| 82043 |
|
12 |
12 |
$21.12 |
| 84100 |
|
116 |
104 |
$8.50 |
| 83615 |
|
15 |
12 |
$5.50 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
45 |
40 |
$0.38 |
| 80076 |
|
539 |
510 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
26 |
24 |
$0.00 |
| 94060 |
|
12 |
12 |
$0.00 |
| 88313 |
|
40 |
25 |
$0.00 |
| 94729 |
|
12 |
12 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
27 |
26 |
$0.00 |
| 96376 |
|
193 |
135 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
12 |
12 |
$0.00 |
| 80320 |
|
28 |
25 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
38 |
28 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
280 |
225 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
32 |
26 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
69 |
68 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
17 |
13 |
$0.00 |